全球細胞培養基市場規模、份額及趨勢分析報告－產業概覽及2031年預測

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare Global Cell Culture Media Market
请求目录 请求目录 与分析师交谈 与分析师交谈 免费样本报告 免费样本报告 购买前请咨询 提前咨询 立即购买 立即购买

全球細胞培養基市場規模、份額及趨勢分析報告－產業概覽及2031年預測

  • Healthcare
  • Published Report
  • Feb 2025
  • Global
  • 350 页面
  • 桌子數： 324
  • 图号： 38
立即购买 立即购买 索取樣品 索取樣品
Nucleus Nucleus

Global Cell Culture Media Market

市场规模（十亿美元）

CAGR :  % Diagram

Chart Image USD 6.23 Billion USD 14.87 Billion 2023 2031
Diagram Forecast Period
 2024 –2031
Diagram Market Size (Base Year)
 USD 6.23 Billion
Diagram Market Size (Forecast Year)
 USD 14.87 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • BD
  • Life TechnologiesTM
  • Thermo Fisher Scientific Inc. Corning Incorporated
  • Sigma-Aldrich Co.
  • Merck KGaA

全球細胞培養基市場細分，按類型（化學定義培養基、經典培養基、無血清培養基、特殊培養基、幹細胞培養基、溶源性肉湯 (LB)、客製化培養基配方等）、應用（生物製藥生產、藥物篩選與開發、診斷、再生醫學與組織工程等）、最終用戶（生物製藥公司、生物技術組織、分銷和研究實驗室、醫院、診斷中心、 20–307–3076767676767676767676767670000 年）產業標準項目

細胞培養基市場

細胞培養基市場分析

細胞培養基市場分析涉及評估細胞培養基市場的全球和區域趨勢、主要參與者、成長因素、挑戰和新興機會。細胞培養基對於實驗室中細胞的生長和維持至關重要，在生物製藥生產、學術研究、藥物發現和再生醫學等領域至關重要。此外，研發支出的增加和疫苗產量的增加推動了市場的成長。

細胞培養基市場細胞培養基市場

細胞培養基市場規模

2023 年全球細胞培養基市場規模為 62.3 億美元，預計到 2031 年將達到 148.7 億美元，預測期內（2024 年至 2031 年）的複合年增長率為 11.5%。除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情境、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。

細胞培養基市場趨勢

“生物製藥計畫研發支出增加”

生物製藥計畫研發支出的增加正在推動全球細胞培養基市場的成長。生物製藥公司正在大力投資研發新的治療方法和療法，這需要使用高品質的細胞培養基來支持生物製品的生長和測試。因此，由於生物製藥公司需要先進的細胞培養基來支持其研發活動，因此對細胞培養基的需求正在增加。例如，2024 年 7 月，根據《經濟時報》發表的一篇文章，對衛生和家庭福利部撥款的修訂估計顯示增加了約。比2022-23年修訂預算高出1.73%。這樣做的目的是開發需要大量研究和開發努力的高價值新藥、生物製藥和生物相似藥。單株抗體、疫苗和基因療法等新生物製品的開發需要使用先進的細胞培養基。這些產品需要特定的生長條件，例如溫度、pH 值和營養水平，這在體外複製可能具有挑戰性。能夠支持這些生物產品的生長和測試的先進細胞培養基正在推動對專用細胞培養基的需求。

報告範圍和細胞培養基市場細分  

屬性

細胞培養基關鍵市場洞察

涵蓋的領域
  • 依類型：化學成分培養基、經典培養基、無血清培養基、特殊培養基、幹細胞培養基、溶源性肉湯（Lb）、客製化培養基配方等
  • 依應用：生物製藥生產、藥物篩選與開發、診斷、再生醫學與組織工程等
  • 按最終用戶：生物製藥公司、生物技術組織、學術和研究實驗室、醫院、診斷中心、細胞庫、法醫實驗室等
  • 按分銷管道：直接投標、第三方分銷和零售

覆蓋國家

美國、加拿大、墨西哥、德國、英國、法國、荷蘭、西班牙、瑞士、比利時、義大利、俄羅斯、土耳其、歐洲其他地區、中國、日本、印度、韓國、澳洲、新加坡、泰國、馬來西亞、印尼、菲律賓、亞太其他地區、巴西、阿根廷、南美洲其他地區、南非、沙烏地阿拉伯、阿聯酋、埃及、以色列、中東和非洲其他地區

主要市場參與者

賽默飛世爾科技公司（美國）、默克公司（MilliporeSigma）（德國）、丹納赫公司（Cytiva）（美國）、龍沙公司（瑞士）、賽多利斯公司（德國）、伯樂實驗室公司（美國）、康寧公司（美國）、通用電氣醫療集團（美國）、BD（碧迪斯公司）（美國）、Hioth Proaborator（美國）、德國） A/S（丹麥）、VWR International, LLC（美國）、智萊生物製品（上海）有限公司（中國）、Vitro Diagnostics Inc.（美國）、Stemcell Technologies, Inc.（加拿大）、Caisson Labs Inc.（美國）、高真生物株式會社（韓國）、InvivoGen（美國）、富士軟片（美國）、高真生物株式會社（韓國）、InvivoGen（美國）、富士膠卷公司（美國）和日本控股美國公司（美國）和日本控股美國）、富士膠卷公司（美國）和日本控股（美國）、富士膠片（美國）、富士膠卷（美國）、日本）、富士膠片（美國）、富士電影（美國）和日本）（日本）、富士膠卷（美國）（日本）等。

市場機會
  • 不斷加強的合作與夥伴關係
  • 生物製藥和疫苗需求增加

加值資料資訊集

除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情景、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。

細胞培養基 市場定義

細胞 培養基是指用於體外培養細胞的培養基的成分、品質和性能的檢查和評估。細胞培養基提供細胞生長和功能所需的必需營養素、生長因子、荷爾蒙和適當的環境。分析這種媒體對於生物技術、製藥和生物醫學研究等各個領域都至關重要。                    

細胞培養基市場動態

驅動程式  

  • 更重視個人化醫療  

對個人化醫療的日益關注正在推動全球細胞培養基市場的成長。透過個人化醫療，患者可以根據其獨特的基因圖譜和疾病特徵獲得客製化的治療方案。這需要使用能夠支持特定細胞或細胞類型生長的高品質細胞培養基，從而推動對專用細胞培養基的需求。例如，2023年3月，根據美國國家醫學圖書館的一篇文章，新科技的發展加速了個人化醫療的成長。個人化醫療的好處包括提高診斷準確性、減少副作用、更好地預防疾病，最重要的是提高病患參與度、降低醫療成本，並促進研究和創新。              

  • 細胞治療和再生醫學的進展             

細胞療法和再生醫學的進步正在推動全球細胞培養基市場的成長。細胞療法涉及使用細胞（例如幹細胞）來治療或預防疾病。再生醫學旨在修復或取代受損的組織、器官或細胞。這兩個領域都需要使用高品質的細胞培養基來支持細胞的生長和分化，這推動了對專用細胞培養基的需求。例如，2023年8月，根據美國國家醫學圖書館發表的一篇文章，幹細胞療法不斷取得進展，為治癒不治之症帶來了希望。此外，幹細胞可以被改造以提供強效藥物或奈米材料，並具有調節免疫系統的能力

細胞培養基市場

機會

  • 不斷加強的合作與夥伴關係

生物製藥公司和學術研究機構之間的策略合作夥伴關係對於推動培養基配方創新變得越來越重要，特別是針對滿足特定研究和臨床要求的配方創新。這些合作可以匯集專業知識、資源和技術，加速新配方和改進配方的開發。學術機構貢獻尖端研究和知識，而生物製藥公司提供商業洞察力、製造能力和監管專業知識。例如，根據《科學家》雜誌發表的一篇文章，2023 年 9 月，Cell Culture Collective, Inc. 很高興宣布與 Defined Bioscience 建立策略夥伴關係。作為合作的一部分，Cell Culture Collective 將作為 Defined Bioscience 優化動物和無血清幹細胞培養產品的授權經銷商。    

  • 生物製藥和疫苗需求增加

由於醫療保健需求不斷增長、人口不斷增長以及對先進醫療方法的認識不斷提高，亞太、南美和中東等新興地區對生物製藥和疫苗的需求正在增加。這種激增為媒體製造商擴大在這些地區的業務創造了重要機會。隨著生物製藥和疫苗生產規模擴大以滿足當地需求，培養基製造商可以提供細胞培養、疫苗生產和治療開發所需的關鍵組件，從而擴大其市場範圍。銷售額和研發支出的快速成長凸顯了對生物製藥和疫苗日益增長的需求，為全球細胞培養基市場帶來了重大機遇，因為產量和研究的增加將推動對專用培養基配方的需求。例如，2024 年 6 月，根據 Medium 發表的一篇文章，隨著全球對創新疫苗的需求不斷增長，製藥公司正轉向亞太地區，因為該地區人口眾多，醫療保健意識不斷增強。亞太新興國家也為地方性傳染病疫苗研發提供了巨大潛力  

限制/挑戰

  • 培養基配方的複雜性    

開發能夠支持多種細胞系的培養基，特別是用於 CAR T 細胞療法、神經幹細胞研究和胚胎幹細胞等高度專業化的應用，需要大量的科學專業知識。每種細胞類型都有不同的營養、環境和生理需求，因此很難創造出適合所有情況的培養基配方。開發過程需要大量的研究、最佳化和測試，以確保培養基能夠支持細胞生長、分化和有效運作，這增加了製造過程的複雜性。例如，根據 BioPharma International 發表的一篇文章，2024 年 6 月，細胞依賴各種化學物質和材料來維持健康和功能。對於生物製藥製造，這些細胞必須高產量、高品質地表達目標產品。基本成分包括提供能量的葡萄糖和碳基糖、提供蛋白質的胺基酸和勝肽、作為酵素輔因子的維生素、建構細胞膜的脂質、維持滲透平衡的鹽以及發揮酵素功能的微量元素。所需培養基成分的複雜性說明了全球細胞培養市場在培養基配方方面的挑戰，因為開發有效且客製化的培養基需要了解不同細胞類型的特定需求。          

  • 生產成本高 

生產成本高是全球細胞培養基市場發展的重大限制因素。細胞培養基的生產過程涉及複雜的配方、高品質的原料以及嚴格的測試和品質控制措施，這會推高成本。此外，生產過程可能需要專門的設備和設施，這也會導致更高的生產成本。因此，細胞培養基市場的製造商在滿足客戶對高品質產品的需求的同時，面臨著保持獲利能力的重大挑戰。高昂的生產成本對於規模較小的生物製藥公司和研究機構來說尤其具有挑戰性，因為它們可能不具備大公司那樣的規模經濟。這些組織可能難以負擔其研發活動所需的高品質細胞培養基，這可能會阻礙他們推動研發計畫的能力。高昂的生產成本也會限制先進細胞培養基技術的採用，減緩新生物製品和療法的開發。

細胞培養基市場範圍

市場根據類型、應用、銷售通路、材料、滾筒直徑、滾筒寬度和農業規模進行細分。這些細分市場之間的成長將幫助您分析行業中成長微弱的細分市場，並為用戶提供有價值的市場概覽和市場洞察，幫助他們做出策略決策，確定核心市場應用。

類型

  • 化學成分確定的培養基
  •  古典媒體
  •  無血清培養基
    • CHO媒體
    •  HEK 293 培養基
    •  CAR-T細胞培養基
    •  VERO細胞培養基
    •  BHK媒體
    •  昆蟲細胞培養基
    •  無血清細胞培養基
    •  其他無血清培養基 
  •  專業媒體
  •  幹細胞培養基
    • 間質幹細胞（MSCS）
    •  神經幹細胞（NSCS）
    •  胚胎幹細胞（ESCS）
    •  骨髓
    •  其他的 
  •  溶源肉湯（LB）
  •  客製化培養基配方
  •  其他的

應用

  • 生物製藥生產
    • 單株抗體
    •  疫苗生產
    •  其他的  
  •  藥物篩選與開發         
  •  診斷
  •  再生醫學與組織工程
    • 幹細胞和基因治療
    •  其他的 
  •  其他的

最終用戶

  • 生物製藥公司
  •  生物技術組織
  •  學術和研究實驗室
  •  醫院
  •  診斷中心
  •  細胞庫
  •  法醫實驗室
  •  其他的 

分銷管道

  • 直接招標
  •  第三方分銷
  •  零售額

細胞培養基市場

細胞培養基市場區域分析

對市場進行分析，並按上述國家、類型、應用、最終用戶和分銷管道提供市場規模洞察和趨勢。

市場涵蓋的國家包括美國、加拿大、墨西哥、德國、英國、法國、荷蘭、西班牙、瑞士、比利時、義大利、俄羅斯、土耳其、歐洲其他地區、中國、日本、印度、韓國、澳洲、新加坡、泰國、馬來西亞、印尼、菲律賓、亞太其他地區、巴西、阿根廷、南美洲其他地區、南非、沙烏地阿拉伯、阿聯酋、埃及、以色列以及中東和非洲其他地區。

由於研發技術的進步、主要參與者的存在以及研發支出的激增，北美預計將主導市場。

由於亞太地區人口快速成長，預計該地區將成為成長最快的地區。政府針對生物製藥產業的措施和投資，以及疫苗的不斷發展，正在促進市場的擴張。

報告的國家部分還提供了影響個別市場因素以及影響市場當前和未來趨勢的國內市場監管變化。下游和上游價值鏈分析、技術趨勢和波特五力分析、案例研究等數據點是用於預測各國市場情景的一些指標。此外，在對國家數據進行預測分析時，還考慮了全球品牌的存在和可用性及其因來自本地和國內品牌的大量或稀缺的競爭而面臨的挑戰、國內關稅和貿易路線的影響。

細胞培養基市場

細胞培養基市場份額

市場競爭格局提供了競爭對手的詳細資訊。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投資、新市場計劃、全球影響力、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度、應用優勢。以上提供的數據點僅與公司對市場的關注有關。

細胞培養基市場領導者包括：

  • 賽默飛世爾科技公司（美國）
  • 默克公司（MilliporeSigma）（德國）
  • 丹納赫公司 (Cytiva)（美國）
  • 龍沙（瑞士）
  • 賽多利斯股份公司（德國）
  • Bio-Rad Laboratories, Inc.（美國）
  • 康寧公司（美國）
  • GE醫療（美國）
  • BD（碧迪公司）（美國）
  • Himedia Laboratories（印度）
  • Promocell（德國）
  • Sera Scandia A/S（丹麥）
  • VWR International, LLC（美國）
  • 智麗生物製品(上海)有限公司 (中國)
  • Vitro Diagnostics Inc.（美國）
  • Stemcell Technologies, Inc.（加拿大）
  • Caisson Labs Inc.（美國）
  • 高真生物株式會社（韓國）
  • InvivoGen（美國）
  • 富士膠片控股美國公司（美國）
  • Takara Bio Inc.（日本）

細胞培養基市場的最新發展

  • 2024年9月，默克在德國、英國、中國和美國的全球細胞培養基生產基地獲得了業界首個EXCiPACT cGMP藥用輔料認證，確保生物製造必需原料的高安全性和品質標準
  • 2024 年 9 月，Cytiva 在韓國仁川松島開設了首個創新中心，其中設有製造工廠和客戶體驗實驗室。該中心旨在加強生物製藥製造，實現可持續的實踐和合作，並支持亞太地區生命科學產業的發展
  • 2024 年 8 月，德國達姆施塔特默克集團生命科學業務部門 MilliporeSigma 以約 6 億美元完成對 Mirus Bio 的收購。這項策略性舉措增強了 MilliporeSigma 的病毒載體生物處理能力，將 Mirus Bio 的先進轉染試劑與其廣泛的生物處理產品組合相結合，以支持細胞和基因治療的進步
  • 2024年7月，默克公司在中國南通啟動了第一條符合GMP標準的細胞培養基生產線，投資金額為72.84億美元。該工廠增強了生產能力，支持了當地生物製藥製造商，並促進了新藥和新療法的更快獲取，從而強化了默克對該地區的承諾
  • 2023 年 7 月，A Sartorius 在其位於波多黎各的 Yauco 工廠正式啟用一個新的 21,500 平方英尺的細胞培養基生產設施。此次擴張增強了賽多利斯生產符合監管要求的粉末培養基的能力，這對於生物製藥生產至關重要。該工廠旨在滿足美洲地區日益增長的需求，並體現了賽多利斯對當地業務的承諾。該工廠將於 2023 年春季投入生產，繼續鞏固賽多利斯在生物製藥行業的地位，並延續其作為該公司在德國境外首個生產基地的傳統。
  • 2023 年 5 月，賽默飛世爾科技與 BRIN 合作，提升印尼的研究能力，重點推動當地研究人員在生命科學、生物技術和環境研究領域的科學創新與合作

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL CELL CULTURE MEDIA MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

5 GLOBAL CELL CULTURE MEDIA MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING FOCUS ON PERSONALIZED MEDICINE

6.1.2 ADVANCES IN CELL THERAPY AND REGENERATIVE MEDICINE

6.1.3 INCREASE IN R&D SPENDING ON BIOPHARMACEUTICAL PROJECTS

6.1.4 GROWING DEMAND FOR VACCINE DEVELOPMENT

6.2 RESTRAINTS

6.2.1 RISKS ASSOCIATED WITH CONTAMINATION

6.2.2 HIGH COST OF PRODUCTION

6.3 OPPORTUNITIES

6.3.1 RISING COLLABORATION AND PARTNERSHIPS

6.3.2 INCREASING DEMAND FOR BIOPHARMACEUTICALS AND VACCINES

6.3.3 INNOVATIONS IN 3D CELL CULTURE

6.4 CHALLENGES

6.4.1 COMPLEXITY OF MEDIA FORMULATION

6.4.2 INTENSE MARKET COMPETITION

7 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE

7.1 OVERVIEW

7.2 CHEMICALLY DEFINED MEDIA CHEMICALLY DEFINED MEDIA

7.3 CLASSICAL MEDIA

7.4 SERUM-FREE MEDIA

7.5 SPECIALTY MEDIA

7.6 STEM CELL MEDIA

7.7 LYSOGENY BROTH (LB)

7.8 CUSTOM MEDIA FORMULATION

7.9 OTHERS

8 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 BIOPHARMACEUTICAL PRODUCTION

8.3 DRUG SCREENING & DEVELOPMENT

8.4 DIAGNOSTICS

8.5 REGENERATIVE MEDICINE & TISSUE ENGINEERING

8.6 OTHERS

9 GLOBAL CELL CULTURE MEDIA MARKET, BY END-USER

9.1 OVERVIEW

9.2 BIOPHARMACEUTICAL COMPANIES

9.3 BIOTECHNOLOGY ORGANIZATIONS

9.4 ACADEMIC AND RESEARCH LABORATORIES

9.5 HOSPITALS

9.6 DIAGNOSTIC CENTERS

9.7 CELL BANKS

9.8 FORENSIC LABORATORIES

9.9 OTHERS

10 GLOBAL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDERS

10.3 THIRD PARTY DISTRIBUTION

10.4 RETAILS SALES

11 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 U.S.

11.2.2 CANADA

11.2.3 MEXICO

11.3 EUROPE

11.3.1 GERMANY

11.3.2 U.K.

11.3.3 FRANCE

11.3.4 NETHERLANDS

11.3.5 SPAIN

11.3.6 SWITZERLAND

11.3.7 BELGIUM

11.3.8 ITALY

11.3.9 RUSSIA

11.3.10 TURKEY

11.3.11 REST OF EUROPE

11.4 SOUTH AMERICA

11.4.1 BRAZIL

11.4.2 ARGENTINA

11.4.3 REST OF SOUTH AMERICA

11.5 MIDDLE EAST AND AFRICA

11.5.1 SOUTH AFRICA

11.5.2 SAUDI ARABIA

11.5.3 U.A.E

11.5.4 EGYPT

11.5.5 ISRAEL

11.5.6 REST OF MIDDLE EAST AND AFRICA

11.6 ASIA-PACIFIC

11.6.1 CHINA

11.6.2 JAPAN

11.6.3 INDIA

11.6.4 SOUTH KOREA

11.6.5 AUSTRALIA

11.6.6 SINGAPORE

11.6.7 THAILAND

11.6.8 MALAYSIA

11.6.9 INDONESIA

11.6.10 PHILIPPINES

11.6.11 REST OF ASIA-PACIFIC

12 GLOBAL CELL CULTURE MEDIA MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: GLOBAL

12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

12.3 COMPANY SHARE ANALYSIS: EUROPE

12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 THERMO FISHER SCIENTIFIC INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 MERCK KGAA

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 DANAHER CORPORATION (CYTIVA)

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 SARTORIUS AG

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 LONZA

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENT

14.6 CORNING INCORPORATED

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 COMPANY SHARE ANALYSIS

14.6.4 PRODUCT PORTFOLIO

14.6.5 RECENT UPDATES

14.7 AJINOMOTO CO., INC

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 AKRON BIOTECH

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 BD

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT UPDATES

14.1 BIO-RAD LABORATORIES, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 REVENUE ANALYSIS

14.10.3 PRODUCT PORTFOLIO

14.10.4 RECENT DEVELOPMENT

14.11 CAISSON LABS INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT UPDATES

14.12 CELL APPLICATION, INC.

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT UPDATES

14.13 ELEX BIOLOGICAL PRODUCTS (SHANGHAI) CO., LTD.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 FUJIFILM HOLDINGS CORPORATION

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT UPDATES

14.15 HIMEDIA LABORATORIES

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT UPDATES

14.16 KOH JIN-BIO CO., LTD.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT UPDATES

14.17 PAN-BIOTECH

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT UPDATES

14.18 PROMOCELL GMBH

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT UPDATES

14.19 SERA-SCANDIA A/S

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 STEMCELL TECHNOLOGIES

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 TAKARA BIO INC.

14.21.1 COMPANY SNAPSHOT

14.21.2 REVENUE ANALYSIS

14.21.3 PRODUCT PORTFOLIO

14.21.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

表格列表

TABLE 1 GMP REQUIREMENTS

TABLE 2 SCOPE OF THE CURRENT DOCUMENT

TABLE 3 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 4 GLOBAL CHEMICALLY DEFINED MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 5 GLOBAL CLASSICAL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 6 GLOBAL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 7 GLOBAL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 8 GLOBAL SPECIALTY MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 9 GLOBAL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 10 GLOBAL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 11 GLOBAL LYSOGENY BROTH (LB) IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 12 GLOBAL CUSTOM MEDIA FORMULATION IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 13 GLOBAL OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 14 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 15 GLOBAL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 16 GLOBAL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 17 GLOBAL DRUG SCREENING & DEVELOPMENT IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 18 GLOBAL DIAGNOSTICS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 19 GLOBAL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 20 GLOBAL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 21 GLOBAL OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 22 GLOBAL CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 23 GLOBAL BIOPHARMACEUTICAL COMPANIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 24 GLOBAL BIOTECHNOLOGY ORGANIZATIONS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 25 GLOBAL ACADEMIC AND RESEARCH LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 26 GLOBAL HOSPITALS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 27 GLOBAL DIAGNOSTIC CENTERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 28 GLOBAL CELL BANKS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 29 GLOBAL FORENSIC LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 30 GLOBAL OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 31 GLOBAL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 32 GLOBAL DIRECT TENDERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 33 GLOBAL THIRD PARTY DISTRIBUTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 34 GLOBAL RETAIL SALES IN CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 35 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION, 2018-2035 (USD MILLION)

TABLE 36 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY COUNTRY, 2018-2035 (USD MILLION)

TABLE 37 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 38 NORTH AMERICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 39 NORTH AMERICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 40 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 41 NORTH AMERICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 42 NORTH AMERICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 43 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 44 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 45 U.S. CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 46 U.S. SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 47 U.S. STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 48 U.S. CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 49 U.S. BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 50 U.S. REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 51 U.S. CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 52 U.S. CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 53 CANADA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 54 CANADA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 55 CANADA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 56 CANADA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 57 CANADA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 58 CANADA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 59 CANADA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 60 CANADA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 61 MEXICO CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 62 MEXICO SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 63 MEXICO STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 64 MEXICO CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 65 MEXICO BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 66 MEXICO REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 67 MEXICO CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 68 MEXICO CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 69 EUROPE CELL CULTURE MEDIA MARKET, BY COUNTRY, 2018-2035 (USD MILLION)

TABLE 70 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 71 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 72 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 73 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 74 EUROPE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 75 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 76 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 77 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 78 GERMANY CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 79 GERMANY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 80 GERMANY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 81 GERMANY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 82 GERMANY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 83 GERMANY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 84 GERMANY CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 85 GERMANY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 86 U.K. CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 87 U.K. SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 88 U.K. STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 89 U.K. CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 90 U.K. BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 91 U.K. REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 92 U.K. CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 93 U.K. CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 94 FRANCE CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 95 FRANCE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 96 FRANCE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 97 FRANCE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 98 FRANCE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 99 FRANCE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 100 FRANCE CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 101 FRANCE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 102 NETHERLANDS CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 103 NETHERLANDS SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 104 NETHERLANDS STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 105 NETHERLANDS CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 106 NETHERLANDS BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 107 NETHERLANDS REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 108 NETHERLANDS CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 109 NETHERLANDS CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 110 SPAIN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 111 SPAIN SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 112 SPAIN STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 113 SPAIN CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 114 SPAIN BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 115 SPAIN REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 116 SPAIN CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 117 SPAIN CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 118 SWITZERLAND CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 119 SWITZERLAND SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 120 SWITZERLAND STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 121 SWITZERLAND CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 122 SWITZERLAND BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 123 SWITZERLAND REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 124 SWITZERLAND CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 125 SWITZERLAND CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 126 BELGIUM CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 127 BELGIUM SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 128 BELGIUM STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 129 BELGIUM CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 130 BELGIUM BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 131 BELGIUM REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 132 BELGIUM CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 133 BELGIUM CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 134 ITALY CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 135 ITALY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 136 ITALY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 137 ITALY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 138 ITALY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 139 ITALY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 140 ITALY CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 141 ITALY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 142 RUSSIA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 143 RUSSIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 144 RUSSIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 145 RUSSIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 146 RUSSIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 147 RUSSIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 148 RUSSIA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 149 RUSSIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 150 TURKEY CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 151 TURKEY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 152 TURKEY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 153 TURKEY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 154 TURKEY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 155 TURKEY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 156 TURKEY CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 157 TURKEY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 158 REST OF EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 159 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY COUNTRY, 2018-2035 (USD MILLION)

TABLE 160 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 161 SOUTH AMERICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 162 SOUTH AMERICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 163 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 164 SOUTH AMERICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 165 SOUTH AMERICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 166 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 167 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 168 BRAZIL CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 169 BRAZIL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 170 BRAZIL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 171 BRAZIL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 172 BRAZIL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 173 BRAZIL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 174 BRAZIL CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 175 BRAZIL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 176 ARGENTINA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 177 ARGENTINA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 178 ARGENTINA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 179 ARGENTINA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 180 ARGENTINA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 181 ARGENTINA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 182 ARGENTINA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 183 ARGENTINA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 184 REST OF SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 185 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY COUNTRY, 2018-2035 (USD MILLION)

TABLE 186 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 187 MIDDLE EAST AND AFRICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 188 MIDDLE EAST AND AFRICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 189 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 190 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 191 MIDDLE EAST AND AFRICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 192 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 193 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 194 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 195 SOUTH AFRICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 196 SOUTH AFRICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 197 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 198 SOUTH AFRICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 199 SOUTH AFRICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 200 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 201 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 202 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 203 SAUDI ARABIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 204 SAUDI ARABIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 205 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 206 SAUDI ARABIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 207 SAUDI ARABIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 208 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 209 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 210 U.A.E CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 211 U.A.E SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 212 U.A.E STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 213 U.A.E CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 214 U.A.E BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 215 U.A.E REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 216 U.A.E CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 217 U.A.E CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 218 EGYPT CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 219 EGYPT SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 220 EGYPT STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 221 EGYPT CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 222 EGYPT BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 223 EGYPT REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 224 EGYPT CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 225 EGYPT CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 226 ISRAEL CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 227 ISRAEL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 228 ISRAEL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 229 ISRAEL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 230 ISRAEL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 231 ISRAEL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 232 ISRAEL CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 233 ISRAEL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 234 REST OF MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 235 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY COUNTRY, 2018-2035 (USD MILLION)

TABLE 236 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 237 ASIA-PACIFIC SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 238 ASIA-PACIFIC STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 239 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 240 ASIA-PACIFIC BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 241 ASIA-PACIFIC REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 242 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 243 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 244 CHINA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 245 CHINA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 246 CHINA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 247 CHINA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 248 CHINA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 249 CHINA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 250 CHINA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 251 CHINA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 252 JAPAN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 253 JAPAN SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 254 JAPAN STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 255 JAPAN CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 256 JAPAN BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 257 JAPAN REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 258 JAPAN CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 259 JAPAN CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 260 INDIA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 261 INDIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 262 INDIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 263 INDIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 264 INDIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 265 INDIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 266 INDIA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 267 INDIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 268 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 269 SOUTH KOREA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 270 SOUTH KOREA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 271 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 272 SOUTH KOREA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 273 SOUTH KOREA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 274 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 275 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 276 AUSTRALIA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 277 AUSTRALIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 278 AUSTRALIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 279 AUSTRALIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 280 AUSTRALIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 281 AUSTRALIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 282 AUSTRALIA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 283 AUSTRALIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 284 SINGAPORE CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 285 SINGAPORE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 286 SINGAPORE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 287 SINGAPORE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 288 SINGAPORE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 289 SINGAPORE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 290 SINGAPORE CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 291 SINGAPORE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 292 THAILAND CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 293 THAILAND SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 294 THAILAND STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 295 THAILAND CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 296 THAILAND BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 297 THAILAND REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 298 THAILAND CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 299 THAILAND CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 300 MALAYSIA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 301 MALAYSIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 302 MALAYSIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 303 MALAYSIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 304 MALAYSIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 305 MALAYSIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 306 MALAYSIA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 307 MALAYSIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 308 INDONESIA CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 309 INDONESIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 310 INDONESIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 311 INDONESIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 312 INDONESIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 313 INDONESIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 314 INDONESIA CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 315 INDONESIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 316 PHILIPPINES CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 317 PHILIPPINES SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 318 PHILIPPINES STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 319 PHILIPPINES CELL CULTURE MEDIA MARKET, BY APPLICATION, 2018-2035 (USD MILLION)

TABLE 320 PHILIPPINES BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 321 PHILIPPINES REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

TABLE 322 PHILIPPINES CELL CULTURE MEDIA MARKET, BY END-USER, 2018-2035 (USD MILLION)

TABLE 323 PHILIPPINES CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD MILLION)

TABLE 324 REST OF ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2018-2035 (USD MILLION)

图片列表

FIGURE 1 GLOBAL CELL CULTURE MEDIA MARKET: SEGMENTATION

FIGURE 2 GLOBAL CELL CULTURE MEDIA MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL CELL CULTURE MEDIA MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL CELL CULTURE MEDIA MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL CELL CULTURE MEDIA MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL CELL CULTURE MEDIA MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL CELL CULTURE MEDIA MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 GLOBAL CELL CULTURE MEDIA MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL CELL CULTURE MEDIA MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL CELL CULTURE MEDIA MARKET: SEGMENTATION

FIGURE 11 EXECUTIVE SUMMARY

FIGURE 12 STRATEGIC DECISIONS BY KEY PLAYERS

FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE IS DRIVING THE GROWTH OF THE GLOBAL CELL CULTURE MEDIA MARKET FROM 2025 TO 2035

FIGURE 14 THE CHEMICALLY DEFINED MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CELL CULTURE MEDIA MARKET IN 2025 AND 2035

FIGURE 15 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL CELL CULTURE MEDIA MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2025 TO 2035

FIGURE 16 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR CELL CULTURE MEDIA MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2025 TO 2035

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL CELL CULTURE MEDIA MARKET

FIGURE 18 GLOBAL CELL CULTURE MEDIA MARKET: BY TYPE, 2024

FIGURE 19 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE, 2025-2035

FIGURE 20 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE, CAGR, 2025-2035

FIGURE 21 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE, LIFE LINE CURVE

FIGURE 22 GLOBAL CELL CULTURE MEDIA MARKET: BY APPLICATION, 2024

FIGURE 23 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION,2025-2035

FIGURE 24 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION, CAGR (2025-2035)

FIGURE 25 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION, LIFE LINE CURVE

FIGURE 26 GLOBAL CELL CULTURE MEDIA MARKET: BY END-USER, 2024

FIGURE 27 GLOBAL CELL CULTURE MEDIA MARKET, BY END USER, (2025-2035)

FIGURE 28 GLOBAL CELL CULTURE MEDIA MARKET, BY END-USER, CAGR (2025-2035)

FIGURE 29 GLOBAL CELL CULTURE MEDIA MARKET, BY END-USER, LIFE LINE CURVE

FIGURE 30 GLOBAL CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 31 GLOBAL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2025-2035

FIGURE 32 GLOBAL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, CAGR, (2025-2035)

FIGURE 33 GLOBAL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, LIFE LINE CURVE

FIGURE 34 GLOBAL CELL CULTURE MEDIA MARKET: SNAPSHOT (2024)

FIGURE 35 GLOBAL CELL CULTURE MEDIA MARKET: COMPANY SHARE 2024 (%)

FIGURE 36 NORTH AMERICA CELL CULTURE MEDIA MARKET: COMPANY SHARE 2024 (%)

FIGURE 37 EUROPE CELL CULTURE MEDIA MARKET: COMPANY SHARE 2024 (%)

FIGURE 38 AISA-PACIFIC MULTIPLE HEREDITARY EXOSTOSIS MARKET: COMPANY SHARE 2024 (%)

查看详细信息 Right Arrow

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

市场是基于 全球細胞培養基市場細分，按類型（化學定義培養基、經典培養基、無血清培養基、特殊培養基、幹細胞培養基、溶源性肉湯 (LB)、客製化培養基配方等）、應用（生物製藥生產、藥物篩選與開發、診斷、再生醫學與組織工程等）、最終用戶（生物製藥公司、生物技術組織、分銷和研究實驗室、醫院、診斷中心、 20–307–3076767676767676767676767670000 年）產業標準項目 进行细分的。
在2023年，全球細胞培養基市場的规模估计为6.23 USD Billion美元。
全球細胞培養基市場预计将在2024年至2031年的预测期内以CAGR 11.5%的速度增长。
市场上的主要参与者包括BD , Life TechnologiesTM , Thermo Fisher Scientific Inc. Corning Incorporated , Sigma-Aldrich Co. , Merck KGaA , GENERAL ELECTRIC COMPANY , Lonza , HiMedia Laboratories. , Takara Bio Inc. , AllCells , PromoCell GmbH , VWR InternationalLLC. , AvantorInc. , Bio-Rad LaboratoriesInc. , Cell Culture Technologies. , FUJIFILM Holdings Corporation , Sartorius AG , Vitro Biopharma , and Eppendorf AG 。

浏览相关页面

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future